🌟 TCT Conference Recap: Prof. Lei Song Unveils Phase III Results of IBS 🌟
At this year’s TCT conference, we were excited to witness Prof. Lei Song’s presentation of the IRONMAN Phase III clinical trial results for IBS! This is an exciting milestone that highlights not only the team’s research excellence but also brings an innovative solution to the field of cardiovascular treatment.
🔹 Ground-breaking Results: Phase III data show that iron-based stents maintain vascular patency with outstanding biocompatibility, significantly reducing the incidence of complications.
🔹 Better for Patients: Compared to traditional stents, iron-based stents offer enhanced degradability and biocompatibility, substantially lowering the burden of long-term follow-up and providing a safer, more effective treatment option for patients.
🔹 Gratitude for the Team's Dedication: Prof. Runlin Gao and Prof. Lei Song with his team have demonstrated rigorous scientific dedication and perseverance, driving progress in cardiovascular medical technology and making high-quality care more accessible.
A huge thank you to all the researchers, clinicians, and patients involved in this project! We look forward to seeing these findings swiftly translated into clinical practice, benefiting more patients.
#CardiovascularInnovation #TCT2024 #IronBasedScaffold #MedTech #ClinicalTrials #HealthTech #Biotyx #IBS #IronBasedScaffold
I know a thing or two because I’ve seen a thing or two.
8moGo get 'em !!!